Brand & Positioning · Biotech
Mannin
From research-based to platform-based — building a biotech brand worthy of a landmark founder.
The challenge
When Jeremy Desai — former President and CEO of Apotex — reached out to build a brand for his biotech company, we rose to the challenge. Mannin had rigorous science at its core, but it was framed like a research project. To attract partners and investors, it needed to be understood as something bigger: a platform.
The mark
An eye for the platform
We built an identity that fuses the human eye with the Ang-Tie2 network — a single mark that signals both the therapeutic focus and the platform thinking behind it. Confident, scientific, and unmistakably Mannin.
The repositioning
From
Research-based company
A single molecule and a research program — valuable, but narrow in how the market could perceive it.
To
Technology & platform-based company
A proprietary Ang-Tie2 mechanism positioned as a foundation partners can build on — glaucoma first, and beyond.
What we did
Brand Identity
A distinctive, confident identity built to earn trust with investors, partners, and the scientific community from day one.
Strategic Positioning
A repositioning from a research-based company to a technology and platform-based company — a single proprietary mechanism others can build on.
Narrative & Messaging
A clear story anchored on the Ang-Tie2 platform, translating deep science into a compelling, ownable market position.
Digital Presence
A modern web presence that communicates the platform vision and the pipeline with clarity and credibility.